Skip to search formSkip to main contentSkip to account menu

Adrenergic beta2-Agonists [MoA]

Known as: Adrenergic beta-2 Agonists, Adrenergic beta2-Agonists, beta-2 Adrenergic Agonists 
National Institutes of Health

Related topics

Related topics

48 relations
10 ML Epinephrine 0.1 MG/ML Prefilled Syringe200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [Proventil]200 ACTUAT Levalbuterol 0.045 MG/ACTUAT Metered Dose Inhaler

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Inverted Variant of Takotsubo Syndrome Caused by Inhaled Adrenergic Beta-2 agonists
Takotsubo syndrome (TS) is an acute and reversible clinical syndrome characterized by transient hypokinesis of the left… 
2016
2016
Beta2-Agonist Doping Control and Optical Isomer Challenges
The World Anti-Doping Agency (WADA) currently allows therapeutic use of the beta2-agonists salbutamol, formoterol and salmeterol… 
1991
1991
A comparative study of the bronchodilator effect and duration of action of liposome encapsulated beta-2 adrenergic agonists in the guinea-pig.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)